Vir Biotechnology Cash Flow Statement (2018-2026) | VIR

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Depreciation and Depletion (Quarter)
5.50M4.60M4.50M4.30M4.40M4.20M2.90M2.70M2.80M2.90M2.90M2.80M2.70M
Share-based Compensation (Quarter)
21.00M22.94M24.37M25.30M27.10M24.81M24.86M25.48M30.62M26.94M28.27M23.76M22.16M16.70M15.84M14.06M12.45M11.36M11.21M12.09M
Deferred Taxes (Quarter)
-1.06M0.06M-2.64M
Gains from Sales and Divestitures (Quarter)
0.09M0.22M0.35M
Gains from Investment Securities (Quarter)
0.63M3.01M-0.19M0.08M0.06M119.89M-8.88M13.10M-12.97M20.76M-20.89M5.92M-5.92M5.53M-6.38M13.97M-11.93M11.66M0.17M
Asset Writedowns and Impairment (Quarter)
2.76M11.04M
Non-cash Items (Quarter)
223.58M181.31M176.40M65.53M52.31M
Cash from Operations (Quarter)
140.06M-105.81M7.70M550.09M960.14M117.90M35.13M-125.78M-389.25M-155.83M-107.93M-109.39M-77.85M-171.48M-87.64M-78.12M-120.22M-167.57M-25.88M-132.39M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.65M0.16M-0.15M0.13M-1.86M2.13M8.54M9.37M3.00M-2.31M-1.35M-0.24M-2.64M-0.35M-2.17M-4.09M-2.52M-1.31M-1.55M-0.39M
Depreciation & Amortization (CF) (Quarter)
1.30M1.40M1.41M1.42M1.50M1.60M2.35M5.64M4.60M4.50M4.48M4.52M4.26M2.90M2.89M2.87M2.92M3.00M2.90M2.81M
Change in Working Capital
Change in Receivables (Quarter)
93.00M680.08M450.08M-883.77M-58.18M-278.17M-2.09M-0.95M3.61M0.40M-2.69M0.05M8.75M
Change in Account Payables (Quarter)
6.25M-5.89M0.79M3.83M-1.39M-4.45M2.80M6.56M-0.93M-7.53M2.63M0.73M-2.89M3.11M-1.94M-1.42M8.86M-5.40M2.96M-4.23M
Change in Accured Expenses (Quarter)
-3.46M8.80M71.99M433.56M-288.18M-80.24M-80.66M-4.04M-265.73M-47.15M-41.92M-30.00M-4.79M19.27M-48.49M18.01M-23.47M-14.15M10.10M-17.22M
Investing Activities
Capital Expenditures (Quarter)
2.11M6.26M13.07M15.84M20.60M18.99M12.57M6.87M9.46M3.71M1.53M1.87M0.67M2.77M2.00M1.63M2.54M0.32M0.35M0.39M
Sales of Property, Plant and Equipment (Quarter)
0.01M-0.00M0.01M-0.02M0.53M0.38M0.01M2.46M0.28M0.04M0.04M-0.11M
Change in Acquisitions & Divestments (Quarter)
128.18M79.86M84.84M266.67M489.46M549.55M447.67M715.71M592.70M483.29M361.51M301.14M301.86M251.32M305.17M342.93M170.60M
Cash from Investing Activities (Quarter)
75.38M73.86M-377.58M-105.39M-272.33M-662.61M-153.13M98.08M230.31M-58.95M-104.81M28.42M211.61M118.60M140.74M126.82M56.46M40.45M86.65M11.84M
Financing Activities
Other financing activities (Quarter)
-0.26M0.10M-0.39M-0.14M-0.04M0.01M0.00M-0.00M
Change in Capital Stock
Shares Issued (Quarter)
3.59M3.69M-7.33M0.48M1.58M1.54M-0.38M2.31M0.29M0.79M0.09M0.22M2.38M-1.81M1.25M0.10M1.45M0.17M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
3.53M3.63M5.67M27.68M3.08M1.99M2.01M2.34M3.18M0.28M1.68M0.15M2.94M0.03M1.26M0.60M2.05M0.10M1.04M162.52M
Change in Cash (Quarter)
218.96M-28.32M-364.22M472.38M690.89M-542.72M-116.00M-25.36M-155.75M-214.51M-211.06M-80.82M136.70M-52.85M54.37M49.30M-61.72M-127.02M61.81M41.97M
Free Cash Flow (Quarter)
137.95M-112.08M-5.37M534.25M939.54M98.91M22.55M-132.65M-398.70M-159.54M-109.46M-111.26M-78.51M-174.25M-89.63M-79.75M-122.76M-167.89M-26.22M-132.78M
Net Cash Flow (Quarter)
218.96M-28.32M-364.22M472.38M690.89M-542.72M-116.00M-25.36M-155.75M-214.51M-211.06M-80.82M136.70M-52.85M54.37M49.30M-61.72M-127.02M61.81M41.97M